Altered CD163 and tweak expression in dendritic cells is associated with cardiac function post-acute myocardial infarction
Immunobiology · 2026
DOI: 10.1016/j.imbio.2026.153166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunobiology, 2026. Verfasst von Marín-Jáuregui Laura Sherell und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medicina Molecular y Traslacional, Centro de Investigación en Ciencias de la Salud y Biomedicina, Facultad de Medicina, Universidad Autónoma de San L…. Hauptthemen laut MEDLINE: Antigens, CD, Receptors, Cell Surface, Cytokine TWEAK, Antigens, Differentiation, Myelomonocytic. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Secretaria de Ciencia Humanidades Tecnologia e Innovacion.
Abstract (Originalsprache)
The activation of the innate immune system is crucial for myocardial recovery after acute myocardial infarction (AMI). Dendritic cells (DCs) and macrophages regulate inflammation and healing of the ischemic heart. This study aims to evaluate the levels of DCs and macrophages expressing CD163 and TWEAK in patients with acute ST-elevation myocardial infarction (STEMI). We decided to evaluate the frequency of CD163+ TWEAK+ DCs and macrophages in patients with STEMI within the first 72 h, as well as at 3 and 6 months after the acute event. We observed that expression of CD163 and TWEAK in myeloid DCs was higher in STEMI patients at 3-month follow-up, and this was associated with worse cardiac function. sTWEAK levels were higher in STEMI patients within 72 h after AMI and positively correlated with a better left ventricular ejection fraction (LVEF). Finally, in M2 Macrophages, rh-TWEAK administration resulted in a dose-dependent decrease in CD163 expression. mDC, pDC, as well as M1/M2 macrophages express CD163 and TWEAK. ages. Our results indicate that TWEAK and CD163 may be promoting an inflammatory milieu after AMI. Thus, an imbalance in the expression of these molecules can then lead to chronic inflammation, tissue damage, and heart failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medicina Molecular y Traslacional, Centro de Investigación en Ciencias de la Salud y Biomedicina, Facultad de Medicina, Universidad Autónoma de San Luis Potosí.
- Departamento de Cardiología, Hospital Central "Ignacio Morones Prieto", Chile.
- Departamento de Medicina Interna, Facultad de Medicina, Universidad Autónoma de San Luis Potosí.
- Medicina Molecular y Traslacional, Centro de Investigación en Ciencias de la Salud y Biomedicina, Facultad de Medicina, Universidad Autónoma de San Luis Potosí. Electronic address: adriana.urenda@uaslp.mx.
Förderung
- Secretaria de Ciencia Humanidades Tecnologia e Innovacion
Zitieren
APA
Sherell, M. L., Berenice, M. E., Martín, C. Á., Ricardo, R. T., Iván, T. A., David, E. C., & Elizabeth, M. A. (2026). Altered CD163 and tweak expression in dendritic cells is associated with cardiac function post-acute myocardial infarction. Immunobiology. https://doi.org/10.1016/j.imbio.2026.153166
Vancouver
Sherell ML, Berenice ME, Martín CÁ, Ricardo RT, Iván TA, David EC, et al. Altered CD163 and tweak expression in dendritic cells is associated with cardiac function post-acute myocardial infarction. Immunobiology. 2026. doi:10.1016/j.imbio.2026.153166
BibTeX
@article{Sherell2026,
author = {Sherell, Marín-Jáuregui Laura and Berenice, Martínez-Shio Elena and Martín, Cárdenas-Hernández Ángel and Ricardo, Ramírez-Torres and Iván, Trujillo-Martíneza Aron and David, Escobedo-Uribe Carlos and Elizabeth, Monsiváis-Urenda Adriana},
title = {Altered CD163 and tweak expression in dendritic cells is associated with cardiac function post-acute myocardial infarction},
journal = {Immunobiology},
year = {2026},
doi = {10.1016/j.imbio.2026.153166}
}
EUVIMED